WockAIR - budesonide with formoterol

Long-acting selective beta2 agonist with corticosteroid.

For asthma, maintenance therapy with WockAIR® 160 mcg/4.5 mcg by inhalation of powder
Adult: Initially 1–2 inhalations twice daily, increased if necessary up to 4 inhalations twice daily; reduced to 1 inhalation daily, dose reduced only if control is maintained.

For asthma, maintenance and reliever therapy with WockAIR® 160 mcg/4.5 mcg by inhalation of powder
Adult: Maintenance 2 inhalations daily in 1–2 divided doses, increased if necessary to 2 inhalations twice daily; 1 inhalation as required, for relief of symptoms, increased if necessary up to 6 inhalations as required, max. 8 inhalations per day; up to 12 inhalations daily can be used for a limited time but medical assessment is recommended.

For chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 70% of predicted (post-bronchodilator) with WockAIR® 160 mcg/4.5 mcg by inhalation of powder
Adult: 2 inhalations twice daily.

For asthma, maintenance therapy with WockAIR® 320 mcg/9 mcg by inhalation of powder
Adult: Initially 1 inhalation twice daily, increased if necessary up to 2 inhalations twice daily; reduced to 1 inhalation daily, dose reduced only if control is maintained.

For chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 70% of predicted (post-bronchodilator) with WockAIR® 320mcg/9 mcg by inhalation of powder
Adult: 1 inhalation twice daily.